These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10599789)

  • 1. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oromandibular dystonia: long-term management with botulinum toxin.
    Sinclair CF; Gurey LE; Blitzer A
    Laryngoscope; 2013 Dec; 123(12):3078-83. PubMed ID: 24122897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
    Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S
    J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.
    Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC
    Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oromandibular dystonia, mental distress and oro-facial dysfunction-A follow-up 8-10 years after start of treatment with botulinum toxin.
    Bakke M; Baram S; Dalager T; Biernat HB; Møller E
    J Oral Rehabil; 2019 May; 46(5):441-449. PubMed ID: 30664806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary management of a partially edentulous patient with oromandibular dystonia: A clinical report.
    Sakar O; Matur Z; Mumcu Z; Sesen P; Oge E
    J Prosthet Dent; 2018 Aug; 120(2):173-176. PubMed ID: 29429838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Rated Communication-Related Quality of Life of Individuals With Oromandibular Dystonia Receiving Botulinum Toxin Injections.
    Page AD; Siegel L; Jog M
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):674-681. PubMed ID: 28654948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of botulinum toxin treatment for oromandibular dystonia.
    Comella CL
    Toxicon; 2018 Jun; 147():96-99. PubMed ID: 29453996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia.
    Adler CH; Factor SA; Brin M; Sethi KD
    Mov Disord; 2002 Jan; 17(1):158-61. PubMed ID: 11835455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
    Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA
    Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients.
    Lo SE; Rosengart AJ; Novakovic RL; Kang UJ; Shah DN; Khan MA; Dalvi A; Goldenberg FD; Macdonald RL; Frank JI
    Neurocrit Care; 2005; 3(2):139-45. PubMed ID: 16174883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin].
    Laskawi R; Rohrbach S
    Laryngorhinootologie; 2001 Dec; 80(12):708-13. PubMed ID: 11793266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive and idiopathic oromandibular dystonia: a clinical comparison.
    Tan EK; Jankovic J
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):186-90. PubMed ID: 10644785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oromandibular dystonia and hormonal factors: twelve years follow-up of a case report.
    Michelotti A; Silva R; Paduano S; Cimino R; Farella M
    J Oral Rehabil; 2009 Dec; 36(12):916-21. PubMed ID: 19840357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oromandibular dystonia involving the lateral pterygoid muscles: four cases with different complexity.
    Møller E; Bakke M; Dalager T; Werdelin LM
    Mov Disord; 2007 Apr; 22(6):785-90. PubMed ID: 17290453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Mar; 12(2):115-8. PubMed ID: 16271495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating severe bruxism with botulinum toxin.
    Tan EK; Jankovic J
    J Am Dent Assoc; 2000 Feb; 131(2):211-6. PubMed ID: 10680389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.